Advancing cancer therapy: The role of MicroRNA in clinical applications

被引：2

作者：

Li, Jianing ^{[1
]}

Zhang, Yongsheng ^{[2
]}

Fu, Tong ^{[3
]}

Xing, Guoli ^{[4
]}

Tong, Ying ^{[4
]}

机构：

[1] Heilongjiang Univ Chinese Med, Harbin, Peoples R China

[2] Harbin Inst Technol, Harbin, Peoples R China

[3] Brandeis Univ, Waltham, MA USA

[4] Heilongjiang Univ Chinese Med, Affiliated Hosp 1, Harbin, Peoples R China

来源：

PHARMACOLOGICAL RESEARCH | 2024年 / 206卷

关键词：

Cancer; MicroRNA; Clinical applications; Therapy; Clinical trials; Therapeutic strategies; FUTURE;

D O I：

10.1016/j.phrs.2024.107299

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页数：3

共 9 条

[1] MicroRNA signatures in human cancers [J].

Calin, George A. ;

Croce, Carlo M. .

NATURE REVIEWS CANCER, 2006, 6 (11) :857-866

[2] Chitosan nanoparticle-mediated delivery of miRNA-34a decreases prostate tumor growth in the bone and its expression induces non-canonical autophagy [J].

Gaur, Sanchaika ;

Wen, Yunfei ;

Song, Jian H. ;

Parikh, Nila U. ;

Mangala, Lingegowda S. ;

Blessing, Alicia M. ;

Ivan, Cristina ;

Wu, Sherry Y. ;

Varkaris, Andreas ;

Shi, Yan ;

Lopez-Berestein, Gabriel ;

Frigo, Daniel E. ;

Sood, Anil K. ;

Gallick, Gary E. .

ONCOTARGET, 2015, 6 (30) :29161-29177

[3] HMGA2 regulation by miRNAs in cancer: Affecting cancer hallmarks and therapy response [J].

Hashemi, Mehrdad ;

Rashidi, Mohsen ;

Hushmandi, Kiavash ;

ten Hagen, Timo L. M. ;

Salimimoghadam, Shokooh ;

Taheriazam, Afshin ;

Entezari, Maliheh ;

Falahati, Mojtaba .

PHARMACOLOGICAL RESEARCH, 2023, 190

[4] Therapeutic targeting of microRNAs: current status and future challenges [J].

Li, Zhonghan ;

Rana, Tariq M. .

NATURE REVIEWS DRUG DISCOVERY, 2014, 13 (08) :622-638

[5] An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics [J].

Liu, Jianfang ;

Lichtenberg, Tara ;

Hoadley, Katherine A. ;

Poisson, Laila M. ;

Lazar, Alexander J. ;

Cherniack, Andrew D. ;

Kovatich, Albert J. ;

Benz, Christopher C. ;

Levine, Douglas A. ;

Lee, Adrian V. ;

Omberg, Larsson ;

Wolf, Denise M. ;

Shriver, Craig D. ;

Thorsson, Vesteinn ;

Hu, Hai .

CELL, 2018, 173 (02) :400-+

[6] Therapeutics in Cancer - An Emerging Concept [J].

Shah, Maitri Y. ;

Ferrajoli, Alessandra ;

Sood, Anil K. ;

Lopez-Berestein, Gabriel ;

Calin, George A. .

EBIOMEDICINE, 2016, 12 :34-42

[7] Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study [J].

Tassone, Pierfrancesco ;

Di Martino, Maria Teresa ;

Arbitrio, Mariamena ;

Fiorillo, Lucia ;

Staropoli, Nicoletta ;

Ciliberto, Domenico ;

Cordua, Alessia ;

Scionti, Francesca ;

Bertucci, Bernardo ;

Salvino, Angela ;

Lopreiato, Mariangela ;

Thunarf, Fredrik ;

Cuomo, Onofrio ;

Zito, Maria Cristina ;

De Fina, Maria Rosanna ;

Brescia, Amelia ;

Gualtieri, Simona ;

Riillo, Caterina ;

Manti, Francesco ;

Caracciolo, Daniele ;

Barbieri, Vito ;

Di Paola, Eugenio Donato ;

Di Francesco, Adele Emanuela ;

Tagliaferri, Pierosandro .

JOURNAL OF HEMATOLOGY & ONCOLOGY, 2023, 16 (01)

[8] MicroRNAs in Helicobacter pylori-infected gastric cancer: Function and clinical application [J].

Xu, Huimei ;

Huang, Ke ;

Shi, Mingxuan ;

Gong, Hang ;

Han, Mengyu ;

Tian, Wenji ;

Wang, Xiaoying ;

Zhang, Dekui .

PHARMACOLOGICAL RESEARCH, 2024, 205

[9] Envisioning the future of early anticancer drug development [J].

Yap, Timothy A. ;

Sandhu, Shahneen K. ;

Workman, Paul ;

de Bono, Johann S. .

NATURE REVIEWS CANCER, 2010, 10 (07) :514-U25

← 1 →